<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3535539/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Risk for Myasthenia Gravis maps to 151Pro→ Ala change in TNIP1 and to HLA-B*08</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535539/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Annals of neurology"><meta name="citation_title" content="Risk for Myasthenia Gravis maps to 151Pro→ Ala change in TNIP1 and to HLA-B*08"><meta name="citation_authors" content="Peter K. Gregersen, Roman Kosoy, Annette T. Lee, Janine Lamb, Jon Sussman, David McKee, Kim R. Simpfendorfer, Ritva Pirskanen-Matell, Frederik Piehl, Qiang Pan-Hammarstrom, J.J.G.M. Verschuuren, Maarten J. Titulaer, Erik H. Niks, Alexander Marx, Philipp Ströbel, Björn Tackenberg, Michael Pütz, Angelina Maniaol, Ahmed Elsais, Chantal Tallaksen, Hanne. F. Harbo, Benedicte A. Lie, Soumya Raychaudhuri, Paul I.W. de Bakker, Arthur Melms, Henri-Jean Garchon, Nicholas Willcox, Lennart Hammarstrom, Michael F. Seldin"><meta name="citation_date" content="December 2012"><meta name="citation_issue" content="6"><meta name="citation_volume" content="72"><meta name="citation_firstpage" content="927"><meta name="citation_doi" content="10.1002/ana.23691"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3535539/?report=abstract"><meta name="citation_pmid" content="23055271"><meta name="DC.Title" content="Risk for Myasthenia Gravis maps to 151Pro→ Ala change in TNIP1 and to HLA-B*08"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Peter K. Gregersen"><meta name="DC.Contributor" content="Roman Kosoy"><meta name="DC.Contributor" content="Annette T. Lee"><meta name="DC.Contributor" content="Janine Lamb"><meta name="DC.Contributor" content="Jon Sussman"><meta name="DC.Contributor" content="David McKee"><meta name="DC.Contributor" content="Kim R. Simpfendorfer"><meta name="DC.Contributor" content="Ritva Pirskanen-Matell"><meta name="DC.Contributor" content="Frederik Piehl"><meta name="DC.Contributor" content="Qiang Pan-Hammarstrom"><meta name="DC.Contributor" content="J.J.G.M. Verschuuren"><meta name="DC.Contributor" content="Maarten J. Titulaer"><meta name="DC.Contributor" content="Erik H. Niks"><meta name="DC.Contributor" content="Alexander Marx"><meta name="DC.Contributor" content="Philipp Ströbel"><meta name="DC.Contributor" content="Björn Tackenberg"><meta name="DC.Contributor" content="Michael Pütz"><meta name="DC.Contributor" content="Angelina Maniaol"><meta name="DC.Contributor" content="Ahmed Elsais"><meta name="DC.Contributor" content="Chantal Tallaksen"><meta name="DC.Contributor" content="Hanne. F. Harbo"><meta name="DC.Contributor" content="Benedicte A. Lie"><meta name="DC.Contributor" content="Soumya Raychaudhuri"><meta name="DC.Contributor" content="Paul I.W. de Bakker"><meta name="DC.Contributor" content="Arthur Melms"><meta name="DC.Contributor" content="Henri-Jean Garchon"><meta name="DC.Contributor" content="Nicholas Willcox"><meta name="DC.Contributor" content="Lennart Hammarstrom"><meta name="DC.Contributor" content="Michael F. Seldin"><meta name="DC.Date" content="2012 Dec"><meta name="DC.Identifier" content="10.1002/ana.23691"><meta name="DC.Language" content="en"><meta property="og:title" content="Risk for Myasthenia Gravis maps to 151Pro→ Ala change in TNIP1 and to HLA-B*08"><meta property="og:type" content="article"><meta property="og:description" content="The objective of this study is to comprehensively define the genetic basis of Early Onset Myasthenia Gravis.We have carried out a two-stage genome-wide association study on a total of 649 North European EOMG patients. Cases were matched 1:4 with controls ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535539/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3535539/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3535539/pdf/nihms392966.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8A992DDD543B1100000000097C0628.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3535539%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3535539</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Ann Neurol</a></span>. Author manuscript; available in PMC 2013 Dec 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=23055271" target="pmc_ext" ref="reftype=publisher&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Ann Neurol. 2012 Dec; 72(6): 927–935. </span></a></div><span class="fm-vol-iss-date">Published online 2012 Oct 10. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1002%2Fana.23691" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1002/ana.23691</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3535539</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS392966</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23055271">23055271</a></div></div></div></div><h1 class="content-title">Risk for Myasthenia Gravis maps to <sup>151</sup>Pro→ Ala change in TNIP1 and to HLA-B*08</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Gregersen%20PK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868356102432" co-class="co-affbox">Peter K. Gregersen</a>,<sup>1</sup> <a href="/pubmed/?term=Kosoy%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868427988384" co-class="co-affbox">Roman Kosoy</a>,<sup>2</sup> <a href="/pubmed/?term=Lee%20AT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868358371296" co-class="co-affbox">Annette T. Lee</a>,<sup>1</sup> <a href="/pubmed/?term=Lamb%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868356099328" co-class="co-affbox">Janine Lamb</a>,<sup>3</sup> <a href="/pubmed/?term=Sussman%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868356097344" co-class="co-affbox">Jon Sussman</a>,<sup>4</sup> <a href="/pubmed/?term=McKee%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394450880" co-class="co-affbox">David McKee</a>,<sup>4</sup> <a href="/pubmed/?term=Simpfendorfer%20KR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394448896" co-class="co-affbox">Kim R. Simpfendorfer</a>,<sup>1</sup> <a href="/pubmed/?term=Pirskanen-Matell%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394446912" co-class="co-affbox">Ritva Pirskanen-Matell</a>,<sup>5</sup> <a href="/pubmed/?term=Piehl%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394444928" co-class="co-affbox">Frederik Piehl</a>,<sup>5</sup> <a href="/pubmed/?term=Pan-Hammarstrom%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394442944" co-class="co-affbox">Qiang Pan-Hammarstrom</a>,<sup>6</sup> <a href="/pubmed/?term=Verschuuren%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394440960" co-class="co-affbox">J.J.G.M. Verschuuren</a>,<sup>7</sup> <a href="/pubmed/?term=Titulaer%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394438976" co-class="co-affbox">Maarten J. Titulaer</a>,<sup>7</sup> <a href="/pubmed/?term=Niks%20EH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868394436992" co-class="co-affbox">Erik H. Niks</a>,<sup>7</sup> <a href="/pubmed/?term=Marx%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868359148608" co-class="co-affbox">Alexander Marx</a>,<sup>8</sup> <a href="/pubmed/?term=Str%26%23x000f6%3Bbel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868359146624" co-class="co-affbox">Philipp Ströbel</a>,<sup>8</sup> <a href="/pubmed/?term=Tackenberg%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868359144640" co-class="co-affbox">Björn Tackenberg</a>,<sup>9</sup> <a href="/pubmed/?term=P%26%23x000fc%3Btz%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868359142656" co-class="co-affbox">Michael Pütz</a>,<sup>9</sup> <a href="/pubmed/?term=Maniaol%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868359140672" co-class="co-affbox">Angelina Maniaol</a>,<sup>10</sup> <a href="/pubmed/?term=Elsais%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868359138688" co-class="co-affbox">Ahmed Elsais</a>,<sup>10</sup> <a href="/pubmed/?term=Tallaksen%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868359136704" co-class="co-affbox">Chantal Tallaksen</a>,<sup>10</sup> <a href="/pubmed/?term=Harbo%20HF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868360232336" co-class="co-affbox">Hanne. F. Harbo</a>,<sup>10</sup> <a href="/pubmed/?term=Lie%20BA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868360230352" co-class="co-affbox">Benedicte A. Lie</a>,<sup>11</sup> <a href="/pubmed/?term=Raychaudhuri%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868360228368" co-class="co-affbox">Soumya Raychaudhuri</a>,<sup>12,</sup><sup>13</sup> <a href="/pubmed/?term=de%20Bakker%20PI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868360225648" co-class="co-affbox">Paul I.W. de Bakker</a>,<sup>12,</sup><sup>13,</sup><sup>14</sup> <a href="/pubmed/?term=Melms%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868360222192" co-class="co-affbox">Arthur Melms</a>,<sup>15</sup> <a href="/pubmed/?term=Garchon%20HJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868360220208" co-class="co-affbox">Henri-Jean Garchon</a>,<sup>16</sup> <a href="/pubmed/?term=Willcox%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868358895584" co-class="co-affbox">Nicholas Willcox</a>,<sup>17</sup> <a href="/pubmed/?term=Hammarstrom%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868358893600" co-class="co-affbox">Lennart Hammarstrom</a>,<sup>6</sup> and  <a href="/pubmed/?term=Seldin%20MF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271" class="affpopup" co-rid="_co_idm139868358891616" co-class="co-affbox">Michael F. Seldin</a><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139868356102432"><h3 class="no_margin">Peter K. Gregersen</h3><p><sup>1</sup>The Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY</p><div>Find articles by <a href="/pubmed/?term=Gregersen%20PK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Peter K. Gregersen</a></div></div><div id="_co_idm139868427988384"><h3 class="no_margin">Roman Kosoy</h3><p><sup>2</sup>Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA</p><div>Find articles by <a href="/pubmed/?term=Kosoy%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Roman Kosoy</a></div></div><div id="_co_idm139868358371296"><h3 class="no_margin">Annette T. Lee</h3><p><sup>1</sup>The Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY</p><div>Find articles by <a href="/pubmed/?term=Lee%20AT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Annette T. Lee</a></div></div><div id="_co_idm139868356099328"><h3 class="no_margin">Janine Lamb</h3><p><sup>3</sup>Centre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK</p><div>Find articles by <a href="/pubmed/?term=Lamb%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Janine Lamb</a></div></div><div id="_co_idm139868356097344"><h3 class="no_margin">Jon Sussman</h3><p><sup>4</sup>Department of Neurology, Greater Manchester Neuroscience Centre, Manchester UK</p><div>Find articles by <a href="/pubmed/?term=Sussman%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Jon Sussman</a></div></div><div id="_co_idm139868394450880"><h3 class="no_margin">David McKee</h3><p><sup>4</sup>Department of Neurology, Greater Manchester Neuroscience Centre, Manchester UK</p><div>Find articles by <a href="/pubmed/?term=McKee%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">David McKee</a></div></div><div id="_co_idm139868394448896"><h3 class="no_margin">Kim R. Simpfendorfer</h3><p><sup>1</sup>The Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY</p><div>Find articles by <a href="/pubmed/?term=Simpfendorfer%20KR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Kim R. Simpfendorfer</a></div></div><div id="_co_idm139868394446912"><h3 class="no_margin">Ritva Pirskanen-Matell</h3><p><sup>5</sup>Department of Neurology, Karolinska University Hospital Solna, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Pirskanen-Matell%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Ritva Pirskanen-Matell</a></div></div><div id="_co_idm139868394444928"><h3 class="no_margin">Frederik Piehl</h3><p><sup>5</sup>Department of Neurology, Karolinska University Hospital Solna, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Piehl%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Frederik Piehl</a></div></div><div id="_co_idm139868394442944"><h3 class="no_margin">Qiang Pan-Hammarstrom</h3><p><sup>6</sup>Division of Clinical Immunology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Pan-Hammarstrom%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Qiang Pan-Hammarstrom</a></div></div><div id="_co_idm139868394440960"><h3 class="no_margin">J.J.G.M. Verschuuren</h3><p><sup>7</sup>Department of Neurology, University Medical Center, Leiden, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Verschuuren%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">J.J.G.M. Verschuuren</a></div></div><div id="_co_idm139868394438976"><h3 class="no_margin">Maarten J. Titulaer</h3><p><sup>7</sup>Department of Neurology, University Medical Center, Leiden, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Titulaer%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Maarten J. Titulaer</a></div></div><div id="_co_idm139868394436992"><h3 class="no_margin">Erik H. Niks</h3><p><sup>7</sup>Department of Neurology, University Medical Center, Leiden, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Niks%20EH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Erik H. Niks</a></div></div><div id="_co_idm139868359148608"><h3 class="no_margin">Alexander Marx</h3><p><sup>8</sup>Department of Pathology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany</p><div>Find articles by <a href="/pubmed/?term=Marx%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Alexander Marx</a></div></div><div id="_co_idm139868359146624"><h3 class="no_margin">Philipp Ströbel</h3><p><sup>8</sup>Department of Pathology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany</p><div>Find articles by <a href="/pubmed/?term=Str%26%23x000f6%3Bbel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Philipp Ströbel</a></div></div><div id="_co_idm139868359144640"><h3 class="no_margin">Björn Tackenberg</h3><p><sup>9</sup>Department of Neurology, University of Marburg, Marburg, Germany</p><div>Find articles by <a href="/pubmed/?term=Tackenberg%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Björn Tackenberg</a></div></div><div id="_co_idm139868359142656"><h3 class="no_margin">Michael Pütz</h3><p><sup>9</sup>Department of Neurology, University of Marburg, Marburg, Germany</p><div>Find articles by <a href="/pubmed/?term=P%26%23x000fc%3Btz%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Michael Pütz</a></div></div><div id="_co_idm139868359140672"><h3 class="no_margin">Angelina Maniaol</h3><p><sup>10</sup>Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Maniaol%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Angelina Maniaol</a></div></div><div id="_co_idm139868359138688"><h3 class="no_margin">Ahmed Elsais</h3><p><sup>10</sup>Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Elsais%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Ahmed Elsais</a></div></div><div id="_co_idm139868359136704"><h3 class="no_margin">Chantal Tallaksen</h3><p><sup>10</sup>Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Tallaksen%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Chantal Tallaksen</a></div></div><div id="_co_idm139868360232336"><h3 class="no_margin">Hanne. F. Harbo</h3><p><sup>10</sup>Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Harbo%20HF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Hanne. F. Harbo</a></div></div><div id="_co_idm139868360230352"><h3 class="no_margin">Benedicte A. Lie</h3><p><sup>11</sup>Institute of Immunology, Oslo University Hospital, Rikshospitalet, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Lie%20BA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Benedicte A. Lie</a></div></div><div id="_co_idm139868360228368"><h3 class="no_margin">Soumya Raychaudhuri</h3><p><sup>12</sup>Department of Medicine, Brigham and Women’s Hospital, Boston, MA</p><p><sup>13</sup>Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA</p><div>Find articles by <a href="/pubmed/?term=Raychaudhuri%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Soumya Raychaudhuri</a></div></div><div id="_co_idm139868360225648"><h3 class="no_margin">Paul I.W. de Bakker</h3><p><sup>12</sup>Department of Medicine, Brigham and Women’s Hospital, Boston, MA</p><p><sup>13</sup>Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA</p><p><sup>14</sup>Julius Center for Health Sciences and Primary Care, and Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=de%20Bakker%20PI%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Paul I.W. de Bakker</a></div></div><div id="_co_idm139868360222192"><h3 class="no_margin">Arthur Melms</h3><p><sup>15</sup>Deparment of Neurology, Tübingen University Medical Center, Tubingen, Germany</p><div>Find articles by <a href="/pubmed/?term=Melms%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Arthur Melms</a></div></div><div id="_co_idm139868360220208"><h3 class="no_margin">Henri-Jean Garchon</h3><p><sup>16</sup>Inserm U1016; CNRS UMR-8104; University Paris Descartes, Paris</p><div>Find articles by <a href="/pubmed/?term=Garchon%20HJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Henri-Jean Garchon</a></div></div><div id="_co_idm139868358895584"><h3 class="no_margin">Nicholas Willcox</h3><p><sup>17</sup>Department ofClinical Neurology, Weatherall Institute for Molecular Medicine, University of Oxford, UK</p><div>Find articles by <a href="/pubmed/?term=Willcox%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Nicholas Willcox</a></div></div><div id="_co_idm139868358893600"><h3 class="no_margin">Lennart Hammarstrom</h3><p><sup>6</sup>Division of Clinical Immunology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Hammarstrom%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Lennart Hammarstrom</a></div></div><div id="_co_idm139868358891616"><h3 class="no_margin">Michael F. Seldin</h3><p><sup>2</sup>Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA</p><div>Find articles by <a href="/pubmed/?term=Seldin%20MF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23055271">Michael F. Seldin</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139868394352368_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139868394352368_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139868394352368_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>The Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Centre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Department of Neurology, Greater Manchester Neuroscience Centre, Manchester UK</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Department of Neurology, Karolinska University Hospital Solna, Stockholm, Sweden</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Division of Clinical Immunology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Department of Neurology, University Medical Center, Leiden, The Netherlands</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Department of Pathology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Department of Neurology, University of Marburg, Marburg, Germany</div><div class="fm-affl" id="A10" lang="en"><sup>10</sup>Department of Neurology, Oslo University Hospital and University of Oslo, Oslo, Norway</div><div class="fm-affl" id="A11" lang="en"><sup>11</sup>Institute of Immunology, Oslo University Hospital, Rikshospitalet, Oslo, Norway</div><div class="fm-affl" id="A12" lang="en"><sup>12</sup>Department of Medicine, Brigham and Women’s Hospital, Boston, MA</div><div class="fm-affl" id="A13" lang="en"><sup>13</sup>Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA</div><div class="fm-affl" id="A14" lang="en"><sup>14</sup>Julius Center for Health Sciences and Primary Care, and Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands</div><div class="fm-affl" id="A15" lang="en"><sup>15</sup>Deparment of Neurology, Tübingen University Medical Center, Tubingen, Germany</div><div class="fm-affl" id="A16" lang="en"><sup>16</sup>Inserm U1016; CNRS UMR-8104; University Paris Descartes, Paris</div><div class="fm-affl" id="A17" lang="en"><sup>17</sup>Department ofClinical Neurology, Weatherall Institute for Molecular Medicine, University of Oxford, UK</div><div id="FN1">Correspondence to: Peter K. Gregersen M.D., Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, 350 Community Drive, Manhasset, New York 11030, telephone 516-562-1542, <a href="mailto:dev@null" data-email="ude.shsn@gretep" class="oemail">ude.shsn@gretep</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139868394352368_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=23055271" target="pmc_ext" ref="reftype=publisher&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Ann Neurol</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3535539/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="6" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp Figure S1.</strong></div><div><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Figure_S1.TIF" data-ga-action="click_feat_suppl">NIHMS392966-supplement-Supp_Figure_S1.TIF</a><span style="color:gray"> (176K)</span></div><div class="small guid">GUID:&nbsp;F5C8D2D5-720A-4715-BCA6-8B26E0B19ECC</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp Table S1.</strong></div><div><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S1.pdf" data-ga-action="click_feat_suppl">NIHMS392966-supplement-Supp_Table_S1.pdf</a><span style="color:gray"> (195K)</span></div><div class="small guid">GUID:&nbsp;AA63F0FC-70FD-4027-9DD8-515738374F20</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp Table S2.</strong></div><div><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S2.pdf" data-ga-action="click_feat_suppl">NIHMS392966-supplement-Supp_Table_S2.pdf</a><span style="color:gray"> (476K)</span></div><div class="small guid">GUID:&nbsp;C9FB2773-6E13-4E22-A810-CFB6191CFC92</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp Table S3.</strong></div><div><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S3.pdf" data-ga-action="click_feat_suppl">NIHMS392966-supplement-Supp_Table_S3.pdf</a><span style="color:gray"> (234K)</span></div><div class="small guid">GUID:&nbsp;CCFA8AA0-84B3-49FC-A5E7-A91F46AF698F</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supp Table S4.</strong></div><div><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S4.pdf" data-ga-action="click_feat_suppl">NIHMS392966-supplement-Supp_Table_S4.pdf</a><span style="color:gray"> (454K)</span></div><div class="small guid">GUID:&nbsp;FB21E45E-DE6B-479B-A9A1-611A57DBB789</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>Supplementary Data.</strong></div><div><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supplementary_Data.doc" data-ga-action="click_feat_suppl">NIHMS392966-supplement-Supplementary_Data.doc</a><span style="color:gray"> (62K)</span></div><div class="small guid">GUID:&nbsp;2530776C-1B08-4158-ADA4-0B50F68D4A71</div></div></dd></dl></div><div id="idm139868355736816" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139868355736816title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Objective</h3><p id="P1" class="p p-first-last">The objective of this study is to comprehensively define the genetic basis of Early Onset Myasthenia Gravis.</p></div><div id="S2" class="sec"><h3 id="S2title">Methods</h3><p id="P2" class="p p-first-last">We have carried out a two-stage genome-wide association study on a total of 649 North European EOMG patients. Cases were matched 1:4 with controls of European ancestry. We performed imputation and conditional analyses across the major histocompatibility complex, as well as in the top regions of association outside the HLA region.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">We observed the strongest association in the HLA class I region at rs7750641 (p = 1.2 × 10<sup>−92</sup>, OR = 6.25). By imputation and conditional analyses, HLA-B*08 proves to be the major associated allele (p = 2.87 × 10<sup>−113</sup>, OR = 6.41). In addition to the expected association with <em>PTPN22</em> (rs2476601, OR =1.71, p = 8.2 ×10<sup>−10</sup>), an imputed coding variant (rs2233290) at position 151 (Pro→Ala) in the TNFAIP3-interacting protein 1, TNIP1, confers even stronger risk than PTPN22 (OR = 1.91, p = 3.2 × 10<sup>−10</sup>).</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Interpretation</h3><p id="P4" class="p p-first-last">The association at TNIP1 in EOMG implies disease mechanisms involving ubiquitin-dependent dysregulation of NF-κB signaling. The localization of the major HLA signal to the HLA-B*08 allele suggests that CD8+ T-cells may play a key role in disease initiation or pathogenesis.</p></div></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P5" class="p p-first">Myasthenia gravis (MG) is a prototypic humoral autoimmune disorder<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935033">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935006">2</a></sup>. It is uncommon, with a prevalence of 1–2 cases per 10,000 overall <sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935011">1</a></sup>. In ~20% of patients, it affects only the eye movements – ‘ocular MG’. In most patients with generalized weakness, it is clearly mediated by autoantibodies against the acetylcholine receptor (AChR) that lead to loss of functional receptors at the motor endplate<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935057">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935065">2</a></sup>. These antibodies can transfer the disease to neonates or experimental animals, and their depletion is an effective therapy<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935012">3</a></sup>. These patients are grouped into the ~25% with early- and the ~40% with late-onset MG (before or after age 45; EOMG or LOMG) and the ~10% with thymomas<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935032">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935049">2</a></sup>. Although the incidence of LOMG appears to be increasing <sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935046">4</a></sup>, few clear HLA or other genetic associations have yet emerged, partly because of further patient heterogeneity<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935031">5</a></sup>. There are been even fewer such clues in patients with thymomas<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935026">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935062">2</a></sup>, possibly because predisposition by these tumors themselves overrides other factors<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935034">6</a></sup></p><p id="P6">In sharp contrast, EOMG in Caucasians is a particularly well defined subgroup, with a 4:1 female bias and characteristic lymph node-like infiltrates in the thymic medulla – i.e. thymic hyperplasia without thymoma<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935010">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935071">2</a></sup> – which are strongly implicated in pathogenesis<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935050">7</a></sup>. Outside of the HLA region, EOMG has been most prominently associated with the R620W PTPN22 risk allele<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935027">8</a></sup>, as is the case for many other humoral autoimmune disorders<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935030">9</a></sup>. In addition, polymorphisms at <em>CHRNA1</em>, which encodes the α-subunit of the AChR are quite strongly but rather specifically associated in EOMG patients with the youngest age of onset. One of these <em>CHRNA1</em> SNPs interacts with the autoimmune regulator, AIRE, and so might affect thymic tolerance induction<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935051">10</a></sup>. However, partly because of its rarity, genome-wide association studies (GWAS) of EOMG have been challenging to organize.</p><p id="P7" class="p p-last">Finally, associations with the common extended HLA “8.1” haplotype (which carries the HLA-A1, -B8 and -DR3 alleles) have long been known in EOMG <sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935072">11</a>–<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935073">13</a></sup>, as in several other highly specific autoimmune disorders and immunodeficiency states<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935040">14</a></sup>. However, the very strong linkage disequilibrium extending over 2 million base pairs across this haplotype has made it difficult to pinpoint causative alleles for most of the associated immunological phenotypes<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935069">15</a></sup>, including MG<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935003">12</a>, <a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935042">13</a>, <a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935056">16</a></sup>. The application of recently developed intensive imputation and conditioning approaches to the analysis of MHC diversity<sup><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935021">17</a></sup> has made this problem more tractable, and now enables us to examine the MHC associations in a large population of patients with EOMG in detail.</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Materials and Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Study subjects</h3><p id="P8" class="p p-first-last">All EOMG cases included in these studies were North European and met the following criteria: <strong>1</strong>) clinical diagnostic criteria for MG; <strong>2</strong>) anti-AChR antibody positive; <strong>3</strong>) no evidence of thymoma; <strong>4</strong>) onset-age &gt;10 years and either &lt;40 years or &lt;45 years with hyperplastic thymic histology. European EOMG cases were collected from multiple centers including: Stockholm, Sweden; Oslo, Norway; Manchester; England, Oxford, England; Paris, France; Leiden, Netherlands, and Tübingen, Germany and Marburg, Germany. Of a combined total of 740 cases collected, 649 cases (400 in discovery and 249 in replication sets) were included in the association testing after exclusions for quality control (&lt;95% complete genotyping data), cryptic relationship analyses (PI^ &gt; 0.15), ancestry analysis and a matching procedure. For several of the collaborating groups the recruitment was only for discovery (e.g. French) or replication (German). For other collaborating groups the initial selection was used for the discovery cohort and a second recruitment was used for the replication cohort. The EOMG cases were 82.9 % female (84.3%, discovery; 80.7%, replication), mean onset-age 25.0 (24.8 discovery; 25.4 replication). These cases were matched 4:1 with controls available from these same populations plus others from European-American populations as described below and as shown in (<a href="#SD2" rid="SD2" class=" supplementary-material">Supplementary Table 1</a>).</p></div><div id="S8" class="sec"><h3 id="S8title">Quality Control</h3><p id="P9" class="p p-first-last">We used stringent quality control criteria to ensure that high-quality data were included in the final analysis. Specifically, we excluded samples with &gt;5% missing data, evidence of cryptic relatedness, or duplicate samples based on identity-by-descent status (PI^ &gt; 0.15) using PLINK<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935076">18</a></sup>. The SNP data were carefully reviewed and exclusion criteria applied to minimize potential batch effects as described below. The application of these criteria was particularly important given the derivation of genotypes from multiple platforms typed in different laboratories. We included only SNPs with &lt;5% missing data, Hardy-Weinberg (H-W) equilibrium p values &gt; 1 × 10<sup>−4</sup> in controls and &gt;1 × 10<sup>−5</sup> in combined cases and controls, minor allele frequency &gt; 0.05%. These procedures were applied in a stepwise approach separately for each dataset. Thus, for each of the separately derived control genotyping sets (<a href="#SD2" rid="SD2" class=" supplementary-material">Table S1</a>), SNPs were excluded if they failed the above criteria within the individual control set (platform and laboratory) or in combination with any of the other control groups, or in the complete data set. The H-W criteria were applied after exclusion of non-European individuals (see Ancestry). Finally, after selection of the control data set (see Matching), SNPs were excluded if allele frequency differed by &gt;10% between different control groups. For the discovery and replication study sets, 281,042 and 527,337 SNPs, respectively, passed these data filters. A total of 274,256 SNPs were common to these two sets and used in the combined analyses.</p></div><div id="S9" class="sec"><h3 id="S9title">Ancestry and Case-Control Matching</h3><p id="P10" class="p p-first-last">European ancestry was determined using a panel of 187 ancestry-informative markers and analyzed using the STRUCTURE v2.1<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935048">19</a>, <a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935052">20</a></sup> program and subjects of known European, Amerindian, East Asian and West African origin as previously described<sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935070">21</a></sup>. We used STRUCTURE to exclude non-European and admixed study participants, since the application of this Bayesian clustering method allows exclusion/inclusion criteria to be set using reference populations. Unlike principal components analysis (PCA), the clustering algorithm can be run under conditions that are not affected by the inclusion of the unknown samples. Briefly, analyses were performed using &gt;100,000 re-samplings and &gt;50,000 burn-in cycles under the admixture model. Runs were performed under the λ = 1 option where λ estimates the prior probability of the allele frequency and is based on the Dirichlet distribution of allele frequencies. Subjects with &gt;15% non-European ancestry were excluded from further analysis. Details of the approach to case-control matching can be found in the <a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Materials</a>. PCA analyses after matching show λ<sub>gc</sub> values of 1.023 and 1.044 for the discovery and replication case/control sets, respectively.</p></div><div id="S10" class="sec"><h3 id="S10title">Analytic Strategy and Association Testing Statistics</h3><p id="P11" class="p p-first-last">We first analyzed the discovery and replication population datasets separately (<a href="#SD3" rid="SD3" class=" supplementary-material">Table S2</a>), and then by combining in two ways: <strong>i</strong>) results from either cases or controls in a meta-analysis applying Cochran–Mantel–Haenszel (CMH) adjustments using PLINK<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935058">18</a>, <a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935025">22</a></sup>, which allows allele and disease frequencies to vary among study populations (treating the discovery and replication phases of the study as separate strata); and <strong>ii</strong>) the genotype data and correction for population substructure. The results of these two methods were so similar (<a href="/pmc/articles/PMC3535539/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>) that we chose (ii) for the main analysis, since there was no strong rationale (e.g. population origin) for treating the two sets as separate strata. Further details on the analytic strategy can be found in the <a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Materials</a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p18">Summary of top association results from GWAS in EOMG</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139868394369424" class="xtable"><table frame="void" rules="none" class="rendered small default_table"><thead><tr><th rowspan="3" colspan="1" valign="bottom" align="left">rs number</th><th rowspan="3" colspan="1" valign="bottom" align="left">Gene</th><th rowspan="3" colspan="1" valign="bottom" align="left">Chr<sup>a</sup></th><th rowspan="3" colspan="1" valign="bottom" align="left">bp<sup>a</sup></th><th rowspan="3" colspan="1" valign="bottom" align="center">Allele Minor/Major</th><th rowspan="3" colspan="1" valign="bottom" align="left">MAF Case<sup>b</sup></th><th rowspan="3" colspan="1" valign="bottom" align="left">MAF Cntl<sup>b</sup>.</th><th colspan="2" rowspan="1" valign="bottom" align="left">Discovery</th><th colspan="2" rowspan="1" valign="bottom" align="left">Replicate</th><th colspan="2" rowspan="1" valign="bottom" align="left">Combined</th><th colspan="2" rowspan="1" valign="bottom" align="left">Meta-Analysis</th><th rowspan="3" colspan="1" valign="bottom" align="left">95% CI</th></tr><tr><th colspan="8" rowspan="1" valign="bottom" align="center">
<hr></th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="left">p value<sup>c</sup></th><th rowspan="1" colspan="1" valign="bottom" align="left">OR<sup>c</sup></th><th rowspan="1" colspan="1" valign="bottom" align="left">p value</th><th rowspan="1" colspan="1" valign="bottom" align="left">OR</th><th rowspan="1" colspan="1" valign="bottom" align="left">p value</th><th rowspan="1" colspan="1" valign="bottom" align="left">OR</th><th rowspan="1" colspan="1" valign="bottom" align="left">p value</th><th rowspan="1" colspan="1" valign="bottom" align="left">OR</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2476601</td><td rowspan="1" colspan="1" valign="top" align="left">PTPN22</td><td rowspan="1" colspan="1" valign="top" align="left">1</td><td rowspan="1" colspan="1" valign="top" align="left">114089610</td><td rowspan="1" colspan="1" valign="top" align="center">A/G</td><td rowspan="1" colspan="1" valign="top" align="left">0.17</td><td rowspan="1" colspan="1" valign="top" align="left">0.11</td><td rowspan="1" colspan="1" valign="top" align="left">6.50E-09</td><td rowspan="1" colspan="1" valign="top" align="left">1.90</td><td rowspan="1" colspan="1" valign="top" align="left">6.24E-03</td><td rowspan="1" colspan="1" valign="top" align="left">1.48</td><td rowspan="1" colspan="1" valign="top" align="left">8.16E-10</td><td rowspan="1" colspan="1" valign="top" align="left">1.71</td><td rowspan="1" colspan="1" valign="top" align="left">3.72E-10</td><td rowspan="1" colspan="1" valign="top" align="left">1.71</td><td rowspan="1" colspan="1" valign="top" align="left">1.44–2.02</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2233287</td><td rowspan="1" colspan="1" valign="top" align="left">TNIP1</td><td rowspan="1" colspan="1" valign="top" align="left">5</td><td rowspan="1" colspan="1" valign="top" align="left">150420290</td><td rowspan="1" colspan="1" valign="top" align="center">A/G</td><td rowspan="1" colspan="1" valign="top" align="left">0.14</td><td rowspan="1" colspan="1" valign="top" align="left">0.09</td><td rowspan="1" colspan="1" valign="top" align="left">4.41E-06</td><td rowspan="1" colspan="1" valign="top" align="left">1.74</td><td rowspan="1" colspan="1" valign="top" align="left">3.85E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.76</td><td rowspan="1" colspan="1" valign="top" align="left">4.55E-09</td><td rowspan="1" colspan="1" valign="top" align="left">1.76</td><td rowspan="1" colspan="1" valign="top" align="left">3.52E-09</td><td rowspan="1" colspan="1" valign="top" align="left">1.73</td><td rowspan="1" colspan="1" valign="top" align="left">1.44–2.08</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs4958881</td><td rowspan="1" colspan="1" valign="top" align="left">TNIP1</td><td rowspan="1" colspan="1" valign="top" align="left">5</td><td rowspan="1" colspan="1" valign="top" align="left">150430429</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="left">0.18</td><td rowspan="1" colspan="1" valign="top" align="left">0.11</td><td rowspan="1" colspan="1" valign="top" align="left">1.22E-05</td><td rowspan="1" colspan="1" valign="top" align="left">1.63</td><td rowspan="1" colspan="1" valign="top" align="left">7.68E-06</td><td rowspan="1" colspan="1" valign="top" align="left">1.89</td><td rowspan="1" colspan="1" valign="top" align="left">3.21E-10</td><td rowspan="1" colspan="1" valign="top" align="left">1.73</td><td rowspan="1" colspan="1" valign="top" align="left">2.55E-10</td><td rowspan="1" colspan="1" valign="top" align="left">1.71</td><td rowspan="1" colspan="1" valign="top" align="left">1.44–2.02</td></tr><tr><td colspan="16" rowspan="1" valign="top" align="left">Other Candidate Autoimmune Susceptibility Genes<sup>d</sup></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs6752770</td><td rowspan="1" colspan="1" valign="top" align="left">STAT4</td><td rowspan="1" colspan="1" valign="top" align="left">2</td><td rowspan="1" colspan="1" valign="top" align="left">191681808</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="left">0.34</td><td rowspan="1" colspan="1" valign="top" align="left">0.29</td><td rowspan="1" colspan="1" valign="top" align="left">1.26E-02</td><td rowspan="1" colspan="1" valign="top" align="left">1.24</td><td rowspan="1" colspan="1" valign="top" align="left">6.36E-03</td><td rowspan="1" colspan="1" valign="top" align="left">1.33</td><td rowspan="1" colspan="1" valign="top" align="left">4.22E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.27</td><td rowspan="1" colspan="1" valign="top" align="left">5.17E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.26</td><td rowspan="1" colspan="1" valign="top" align="left">1.11–1.43</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1026421</td><td rowspan="1" colspan="1" valign="top" align="left">IKZF1</td><td rowspan="1" colspan="1" valign="top" align="left">7</td><td rowspan="1" colspan="1" valign="top" align="left">50291272</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="left">0.29</td><td rowspan="1" colspan="1" valign="top" align="left">0.34</td><td rowspan="1" colspan="1" valign="top" align="left">4.63E-03</td><td rowspan="1" colspan="1" valign="top" align="left">0.78</td><td rowspan="1" colspan="1" valign="top" align="left">4.70E-02</td><td rowspan="1" colspan="1" valign="top" align="left">0.80</td><td rowspan="1" colspan="1" valign="top" align="left">4.38E-04</td><td rowspan="1" colspan="1" valign="top" align="left">0.79</td><td rowspan="1" colspan="1" valign="top" align="left">3.46E-04</td><td rowspan="1" colspan="1" valign="top" align="left">0.79</td><td rowspan="1" colspan="1" valign="top" align="left">0.69–0.90</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs729302</td><td rowspan="1" colspan="1" valign="top" align="left">IRF5</td><td rowspan="1" colspan="1" valign="top" align="left">7</td><td rowspan="1" colspan="1" valign="top" align="left">128356196</td><td rowspan="1" colspan="1" valign="top" align="center">C/A</td><td rowspan="1" colspan="1" valign="top" align="left">0.27</td><td rowspan="1" colspan="1" valign="top" align="left">0.33</td><td rowspan="1" colspan="1" valign="top" align="left">1.24E-03</td><td rowspan="1" colspan="1" valign="top" align="left">0.75</td><td rowspan="1" colspan="1" valign="top" align="left">5.17E-03</td><td rowspan="1" colspan="1" valign="top" align="left">0.73</td><td rowspan="1" colspan="1" valign="top" align="left">2.32E-05</td><td rowspan="1" colspan="1" valign="top" align="left">0.74</td><td rowspan="1" colspan="1" valign="top" align="left">2.45E-05</td><td rowspan="1" colspan="1" valign="top" align="left">0.75</td><td rowspan="1" colspan="1" valign="top" align="left">0.65–0.86</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs11190140</td><td rowspan="1" colspan="1" valign="top" align="left">NKX2-3</td><td rowspan="1" colspan="1" valign="top" align="left">10</td><td rowspan="1" colspan="1" valign="top" align="left">101281583</td><td rowspan="1" colspan="1" valign="top" align="center">A/G</td><td rowspan="1" colspan="1" valign="top" align="left">0.52</td><td rowspan="1" colspan="1" valign="top" align="left">0.47</td><td rowspan="1" colspan="1" valign="top" align="left">7.87E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.31</td><td rowspan="1" colspan="1" valign="top" align="left">1.88E-01</td><td rowspan="1" colspan="1" valign="top" align="left">1.14</td><td rowspan="1" colspan="1" valign="top" align="left">4.44E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.25</td><td rowspan="1" colspan="1" valign="top" align="left">4.61E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.24</td><td rowspan="1" colspan="1" valign="top" align="left">1.10–1.40</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs9303277</td><td rowspan="1" colspan="1" valign="top" align="left">ORMDL3</td><td rowspan="1" colspan="1" valign="top" align="left">17</td><td rowspan="1" colspan="1" valign="top" align="left">35229995</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="left">0.42</td><td rowspan="1" colspan="1" valign="top" align="left">0.48</td><td rowspan="1" colspan="1" valign="top" align="left">3.42E-02</td><td rowspan="1" colspan="1" valign="top" align="left">0.84</td><td rowspan="1" colspan="1" valign="top" align="left">4.14E-05</td><td rowspan="1" colspan="1" valign="top" align="left">0.66</td><td rowspan="1" colspan="1" valign="top" align="left">1.48E-05</td><td rowspan="1" colspan="1" valign="top" align="left">0.76</td><td rowspan="1" colspan="1" valign="top" align="left">1.25E-05</td><td rowspan="1" colspan="1" valign="top" align="left">0.76</td><td rowspan="1" colspan="1" valign="top" align="left">0.67–0.86</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs1790588</td><td rowspan="1" colspan="1" valign="top" align="left">CD226</td><td rowspan="1" colspan="1" valign="top" align="left">18</td><td rowspan="1" colspan="1" valign="top" align="left">65686164</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="left">0.54</td><td rowspan="1" colspan="1" valign="top" align="left">0.48</td><td rowspan="1" colspan="1" valign="top" align="left">7.12E-04</td><td rowspan="1" colspan="1" valign="top" align="left">0.76</td><td rowspan="1" colspan="1" valign="top" align="left">1.96E-01</td><td rowspan="1" colspan="1" valign="top" align="left">1.14</td><td rowspan="1" colspan="1" valign="top" align="left">4.92E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.24</td><td rowspan="1" colspan="1" valign="top" align="left">3.97E-04</td><td rowspan="1" colspan="1" valign="top" align="left">1.25</td><td rowspan="1" colspan="1" valign="top" align="left">1.10–1.41</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">rs2431697</td><td rowspan="1" colspan="1" valign="top" align="left">PTTG1</td><td rowspan="1" colspan="1" valign="top" align="left">5</td><td rowspan="1" colspan="1" valign="top" align="left">159812556</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="left">0.37</td><td rowspan="1" colspan="1" valign="top" align="left">0.43</td><td rowspan="1" colspan="1" valign="top" align="left">4.00E-04</td><td rowspan="1" colspan="1" valign="top" align="left">0.75</td><td rowspan="1" colspan="1" valign="top" align="left">1.18E-02</td><td rowspan="1" colspan="1" valign="top" align="left">0.77</td><td rowspan="1" colspan="1" valign="top" align="left">1.43E-05</td><td rowspan="1" colspan="1" valign="top" align="left">0.76</td><td rowspan="1" colspan="1" valign="top" align="left">1.38E-05</td><td rowspan="1" colspan="1" valign="top" align="left">0.76</td><td rowspan="1" colspan="1" valign="top" align="left">0.64–0.8</td></tr></tbody></table></div><div id="largeobj_idm139868394369424" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3535539/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><sup>a</sup>The chromosome (Chr) and base-pair (bp) position (HG18) are shown.</div><div id="TFN2"><sup>b</sup>Minor allele frequency (MAF) for cases and controls (Cntl) for the combined Discovery and Replication datasets.</div><div id="TFN3"><sup>c</sup>The p value and odds ratio (OR) were determined using an additive model including covariates for gender and principal components (see Methods). For the combined analyses the Discovery and Replication datasets were combined and adjusted for the covariates and for the Meta-Analysis, Cochran-Mantel-Haenzel adjustments were used to combine the datasets.</div><div id="TFN4"><sup>d</sup>See <a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Table 5</a> for comparisons of these genes in different autoimmune disease.</div></div></div></div><div id="S11" class="sec"><h3 id="S11title">Attributable Risk Calculations</h3><p id="P12" class="p p-first-last">The percent population attributable risk (PAR) was estimated for each individual locus: PAR = Σp<sub>i</sub> × (OR<sub>i</sub> − 1)/(Σp<sub>i</sub> × (OR<sub>i</sub> − 1) + 1), in which p<sub>i</sub> is the prevalence of risk allele at i<sup>th</sup> locus among control subjects, and OR<sub>i</sub> is OR of risk allele at ith locus. The joint PAR was calculated using the individual PAR for each of the associated SNPs: 1 − Π (1 − PAR<sub>i</sub>) in which PAR<sub>i</sub> is the individual PAR for each associated SNP.</p></div><div id="S12" class="sec sec-last"><h3 id="S12title">Imputation of HLA determinants and Conditional Association Tests in the MHC</h3><p id="P13" class="p p-first-last">To impute HLA determinants, we utilized a separate reference dataset collected by the Type 1 Diabetes Genetics Consortium (T1DGC). The Beagle software package<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935039">23</a></sup> was used for imputation in our dataset and only SNPs with posterior probabilities of &gt;0.90 were included in our final analyses. SNPTEST V2.0<sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935061">24</a></sup> (see web resources) was used for the primary association analyses for the imputed genotypes, as well as for conditional analyses across the MHC, as described in the <a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Materials</a>.</p></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">Results</h2><p id="P14" class="p p-first"><a href="/pmc/articles/PMC3535539/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a> shows a Manhattan plot of the GWAS results for the combined analysis using 649 EOMG cases matched with 2596 controls (λ<sub>gc</sub> = 1.046). As expected, the strongest association was within the MHC – at rs7750641 (p = 1.2 × 10<sup>−92</sup>, OR = 6.25 (95% CI 4.89 – 6.85). The full results for the MHC region are given in <a href="#SD3" rid="SD3" class=" supplementary-material">Supplementary Table 2</a>. Two additional loci outside the MHC achieved genome-wide levels of significance for association (<a href="/pmc/articles/PMC3535539/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a> and <a href="/pmc/articles/PMC3535539/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>): <em>PTPN22</em> (rs2476601, OR = 1.71, p = 8.2 × 10<sup>−10</sup>), and an equally strong association with TNFAIP3-interacting protein 1 (<em>TNIP1</em>; rs4958881 OR = 1.73, p = 3.2 × 10<sup>−10</sup>). We also examined selected validated SNPs showing associations in other major PTPN22-associated autoimmune diseases<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_317238775">25</a>–<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_493550012">27</a></sup>; seven candidate gene regions achieved p&lt;5 ×10<sup>−4</sup> in the combined analysis (<a href="/pmc/articles/PMC3535539/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), consistent with the increased frequencies of other autoimmune disorders in EOMG patients and blood relatives<sup><a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935038">28</a></sup>. Notably, TNFAIP3, a binding partner of TNIP1, did not show significant evidence of association or interaction with TNIP1 (data not shown).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3535539/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139868360156384" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms392966f1.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms392966f1.jpg" src="/pmc/articles/PMC3535539/bin/nihms392966f1.jpg"></div></a><div id="largeobj_idm139868360156384" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC3535539/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC3535539/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3535539/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p15">Manhattan plot of association signals in early-onset myasthenia gravis (EOMG). The strength of association (-log<sub>10</sub> p values; ordinate) is plotted against the position on each chromosome in base pairs (abscissa). Details of markers achieving p &lt;5 × 10<sup>−4</sup> are provided in <a href="#SD3" rid="SD3" class=" supplementary-material">Supplementary Table 2</a>.</p></div></div></div><p id="P15">Imputation and conditional analysis in the region around <em>TNIP1</em> using ImputeV2.0 and SNPTEST v2 <sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935035">24</a></sup> revealed an association with rs2233290, a variant encoding a non-conservative <sup>151</sup>Pro→Ala in TNIP1 (<a href="/pmc/articles/PMC3535539/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>, and <a href="#SD4" rid="SD4" class=" supplementary-material">Supplementary Table 3</a>). The minor allele of rs223290, imputed based on 1,000 Genomes Project data (posterior probability = 0.96), also showed a strong association with EOMG (OR = 1.92, 95%CI: 1.54 – 2.38, p = 3.4 ×10<sup>−9</sup>). Controlling for rs2233290 showed only modest evidence (p&gt;1 × 10<sup>−4</sup>) for residual signals at this locus (<a href="/pmc/articles/PMC3535539/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3535539/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139868394380160" class="figure"><a href="/pmc/articles/PMC3535539/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3535539_nihms392966f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms392966f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3535539/bin/nihms392966f2.jpg"></a></div><div id="largeobj_idm139868394380160" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3535539/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3535539/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p16"><em>TNIP1</em> association signals in EOMG. Association signals were examined after inclusion of imputation results using 1000 Genome sequencing data and the genotyped SNPs (diamond symbols) and imputed SNPs (circles) are shown. The ordinate shows the strength of the association signals, with the position on chromosome 5 shown in Mb (HG18 map) along the abscissa. The p value for each SNP is shown before (<strong>a</strong>) and after conditioning with rs2233290 (<strong>b</strong>), a SNP that encodes a <sup>151</sup>Pro→Ala change. The color-coded symbols correspond to the strength of linkage disequilibrium (r<sup>2</sup>), showing the most significant associated SNP (rs1559127) as a blue circle. See <a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Materials</a> for imputation methods and details for imputed SNPs and results (<a href="#SD4" rid="SD4" class=" supplementary-material">Supplementary Table 3</a>).</p></div></div></div><p id="P16">We next used a comprehensive imputation approach<sup><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935007">17</a></sup> to enable association testing of HLA alleles across the MHC region. For this association testing, we used the probabilities for each genotype (including only variants with an average posterior probability &gt;0.9), together with covariates for sex and the top five principal components, to correct for population substructure. Using this dataset, the most significant association was for HLA-B*08 (p = 2.87 × 10<sup>−113</sup>, see <a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3a</span></a>), with OR = 6.41 (95%CI 5.46 – 7.53). After conditioning on HLA-B*08, the other signals dropped over 10-fold in significance, leaving some modest residual associations around HLA-B as well as in the class II region (<a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139868394372000" class="figure"><a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3535539_nihms392966f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms392966f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3535539/bin/nihms392966f3.jpg"></a></div><div id="largeobj_idm139868394372000" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3535539/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3535539/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p17">Analysis of the HLA region association signals in EOMG. In each panel, the symbols show the strength of the association signal (ordinate) for this region of chromosome 6 shown in Mb (HG18) along the abscissa; the SNPs and HLA determinants are given color-coded symbols as described in <a href="/pmc/articles/PMC3535539/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>. For <strong>a,</strong> the −Log<sub>10</sub> p value before conditioning is shown. For <strong>b–d</strong> the −Log<sub>10</sub> p values are shown after conditioning on the indicated HLA determinant(s). See <a href="#SD6" rid="SD6" class=" supplementary-material">Supplementary Materials</a> for methods and additional conditioning studies (<a href="#SD5" rid="SD5" class=" supplementary-material">Supplementary Table 4</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Fig. S1</a>).</p></div></div></div><p id="P17">Notably, the signal at HLA-DRB1*0301, prior to conditioning on HLA-B*08, was substantially weaker (DRB1*0301, p = 9.7 × 10<sup>−74</sup> vs. HLA-B*08, 2.87 × 10<sup>−113</sup>). In addition, conditioning on this association only reduced the HLA-B*08 signal to p = 4.7 × 10<sup>−45</sup> (<a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3c</span></a>) whereas conditioning on B*08 completely eliminated the DRB1*0301 signal. Similarly for the HLA class III region (between HLA-B and HLA-DR), the signal was substantially lower than that of HLA-B*08 (<a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3a</span></a>); it also lost all significance after conditioning on HLA-B*08 (<a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3b</span></a>).</p><p id="P18">Further conditioning on all HLA-B alleles that showed associations in the unconditioned analysis (P&lt;0.01) substantially eliminated residual evidence of other associations in the MHC class I region (p&gt; 1 ×10<sup>−6</sup>), but left a significant residual signal (p&lt;5 × 10<sup>−8</sup>) in the class II region (<a href="/pmc/articles/PMC3535539/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3d</span></a>). Most of these remaining signals were due to DRB1*16 (predisposing) and DRB1*0701 (protective), consistent with previous studies reporting modest positive and negative associations with these alleles in MG with thymic hyperplasia<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935009">5</a></sup>. Further conditioning on these alleles, as well as for a minor effect observed at HLA-A*3101, eliminated all significant association in the region (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 1</a> and <a href="#SD5" rid="SD5" class=" supplementary-material">Supplementary Table 4</a>). Notably, the HLA-DR*0301 allele of the 8.1 haplotype no longer contributed signals at DRB1 – which is consistent with previous reports that HLA-DRB1*03 is rarely a restricting element for AChR-specific T-cells<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935008">7</a></sup>, and may in fact reduce the risk of high titers of anti-AChR antibodies<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935074">13</a></sup>.</p><p id="P19" class="p p-last">We saw no clear signs of interactions between the predisposing PTPN22, TNIP1 and HLA alleles. However, since a previous report suggested a possible interaction between sex and HLA genotype<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935053">12</a></sup>, we examined evidence for this in our larger dataset. As shown in <a href="/pmc/articles/PMC3535539/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>, we confirmed a stronger association of HLA-B8 with EOMG in females (OR= 6.92; 95% CI 4.28–5.91) compared with males (OR 3.55; 95% CI 2.46–4.56), which is significantly different when a direct comparison is made between the two groups (P&lt;0.0001).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p23">Effect of Gender on EOMG Associations</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139868357611008" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" valign="bottom" align="center">gender<sup>a</sup></th><th rowspan="1" colspan="1" valign="bottom" align="center">locus</th><th rowspan="1" colspan="1" valign="bottom" align="center">marker</th><th rowspan="1" colspan="1" valign="bottom" align="center">OR<sup>b</sup></th><th rowspan="1" colspan="1" valign="bottom" align="center">OR 95% CI</th><th rowspan="1" colspan="1" valign="bottom" align="center">p-value</th><th rowspan="1" colspan="1" valign="bottom" align="center">gender p<sup>c</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">Female</td><td rowspan="1" colspan="1" valign="top" align="center">PTPN22</td><td rowspan="1" colspan="1" valign="top" align="center">rs2476601</td><td rowspan="1" colspan="1" valign="top" align="center">1.72</td><td rowspan="1" colspan="1" valign="top" align="center">1.42 – 2.10</td><td rowspan="1" colspan="1" valign="top" align="center">6.02E-08</td><td rowspan="2" colspan="1" valign="middle" align="center">0.93</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Male</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">1.71</td><td rowspan="1" colspan="1" valign="top" align="center">1.16 – 2.51</td><td rowspan="1" colspan="1" valign="top" align="center">6.46E-03</td></tr><tr><td colspan="7" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Female</td><td rowspan="1" colspan="1" valign="top" align="center">TNIP1</td><td rowspan="1" colspan="1" valign="top" align="center">rs4958881</td><td rowspan="1" colspan="1" valign="top" align="center">1.73</td><td rowspan="1" colspan="1" valign="top" align="center">1.42 – 2.12</td><td rowspan="1" colspan="1" valign="top" align="center">6.77E-08</td><td rowspan="2" colspan="1" valign="middle" align="center">0.76</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Male</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">1.80</td><td rowspan="1" colspan="1" valign="top" align="center">1.23 – 2.62</td><td rowspan="1" colspan="1" valign="top" align="center">2.50E-03</td></tr><tr><td colspan="7" rowspan="1" valign="bottom" align="left">
<hr></td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Female</td><td rowspan="1" colspan="1" valign="top" align="center">MHC</td><td rowspan="1" colspan="1" valign="top" align="center">HLA_B*08</td><td rowspan="1" colspan="1" valign="top" align="center">6.92</td><td rowspan="1" colspan="1" valign="top" align="center">4.28 – 5.91</td><td rowspan="1" colspan="1" valign="top" align="center">8.48E-96</td><td rowspan="2" colspan="1" valign="middle" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">Male</td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center"></td><td rowspan="1" colspan="1" valign="top" align="center">3.55</td><td rowspan="1" colspan="1" valign="top" align="center">2.46 – 4.56</td><td rowspan="1" colspan="1" valign="top" align="center">1.89E-13</td></tr></tbody></table></div><div id="largeobj_idm139868357611008" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3535539/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><sup>a</sup>The number of female cases was 538 and the number of male cases was 111. The female and male analyses were matched 3:1 and 8:1with controls, respectively. All analyses were controlled for population substructure as in the main analyses.</div><div id="TFN6"><sup>b</sup>OR, odds ratio.</div><div id="TFN7"><sup>c</sup>The p-valuefor gender difference was calculated using an unpaired T test.</div></div></div></div><div id="S14" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S14title">Discussion</h2><p id="P20" class="p p-first">Our GWAS analysis of EOMG has yielded two observations of particular interest, spotlighting, for the first time, an association with a non-synonymous change in <em>TNIP1</em> – with an effect size that rivals PTPN22 – and convincingly localizing the major MHC association to the class I HLA-B locus. As is typical of most genetic associations with autoimmune diseases<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935059">9</a></sup>, these risk alleles are quite common in the population, with carrier rates in patients of 62.1% (vs 20.3% in controls) for HLA-B*08 and 27.0% (vs 16.9%) for TNIP1 <sup>151</sup>Ala. Both of these findings have implications for understanding the immuno-pathogenesis of EOMG.</p><p id="P21">TNIP1 (also known as A20-binding inhibitor of NF-κB1, or ABIN1) is a member of a family of related molecules with a common ubiquitin-binding domain and other shared domains involved in interactions with TNFAIP3 and NEMO as well some other members of the NFκB family<sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935044">29</a></sup>. Like TNFAIP3 (also designated A20), TNIP1 has inhibitory activities, and its over-expression reduces the NF-κB1 activation induced by TNF, IL-1 and LPS<sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935043">29</a></sup>. Knock-out animals usually die <em>in utero</em> or shortly after birth from uncontrolled apoptotic cell death<sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935028">30</a></sup>. Interestingly, mice with a knock-in mutation disrupting the ubiquitin-binding domain of TNIP1 showed autoimmune features including elevated immunoglobulin levels, anti-dsDNA autoantibodies, and glomerulonephritis<sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935022">31</a></sup>. These immunological abnormalities are primarily in B-cells and myeloid cells, not T-cells, with prominent hyperactivation through TLR4 and TLR2/6 pathways as well as through the B-cell receptor and CD40<sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935037">31</a></sup>. Interestingly, a recent report suggests that TNIP1 may also act through pathways that converge on the transcription factor C/EBPb, which appear to be independent of TNFAIP3 regulation<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935060">32</a></sup>. This may be particularly relevant given the lack of association with TNFAIP3 with EOMG.</p><p id="P22">The <sup>151</sup>Pro→Ala change in TNIP1 is not located within any of the known ubiquitin-binding or protein interaction domains. However, the <sup>151</sup>Pro is highly conserved across species, and both PolyPhen-2<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935015">33</a></sup> (Score = 0.98) and other algorithms based on protein structural stability predict that the Ala replacement is deleterious<sup><a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935017">34</a></sup>. These data thus implicate the TNIP1 <sup>151</sup>Ala replacement itself in EOMG pathogenesis, although without direct functional data, this remains a hypothesis to be proven. The substantial prevalence of this variant in northern Europeans (carrier rate ~16%) should facilitate future detailed studies of its immune functions in healthy carriers, analogous to those recently reported for PTPN22<sup><a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935066">35</a></sup>. Notably, several markers in strong linkage disequilibrium (LD) with rs2233290 show associations in systemic lupus erythematosus<sup><a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935067">36</a></sup> and systemic sclerosis<sup><a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935063">37</a></sup>, while those in psoriasis are with SNPs that clearly do not involve this haplotype<sup><a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935055">38</a></sup>, suggesting a distinct functional role for TNIP1 in the latter disease.</p><p id="P23">In addition to the involvement of TNIP1, our data argue strongly that the major MHC associations in EOMG are with the classical class I allele HLA-B*08 itself, and to a much lesser extent with selected alleles at HLA-DRB1. Of note, DRB1*07 provides a protective effect as shown previously<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935014">5</a></sup>, further emphasizing the complex relationships between HLA and EOMG. Further, we cannot definitively exclude additional contributions from other MHC loci, such as HLA-C. Indeed, after conditioning on HLA-B*08, further conditioning on selected HLA-C alleles gives a rather similar result to the addition of full HLA-B conditioning (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig 1b</a>), emphasizing the challenges of analyzing genomic regions with strong LD. However, the major effect of HLA-B*08 itself cannot be parsimoniously explained by other alleles, either alone or in combination, e.g., at the HLA-C locus or, for that matter, HLA-DRB1 and other HLA classical alleles.</p><p id="P24">Interestingly, we have observed a striking difference in risk for HLA-B8 when comparing female and male patients with MG, confirming previous observations<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935068">12</a></sup>. This interaction between sex and HLA risk has been observed in other autoimmune disorders, most recently in SLE<sup><a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935029">39</a></sup>, but with much less dramatic differences than seen in MG. In the case of SLE, increased risk with HLA was found in males, not females as we have reported here. Our findings in MG may reflect hormonal effects, a female bias in environmental exposure or gender related epigenetic changes as playing a role in disease risk. Interestingly, we did not find any association with the estrogen receptor alpha (ESRRA) in either the entire subject set or in females alone (p &gt; 0.05 for all SNPS +/− 200 kb) although this gene has been suggested as a possible candidate for EOMG based on expression studies<sup><a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935024">40</a></sup>.</p><p id="P25">The highly mutated high affinity IgG autoantibody responses in EOMG, which must be T-cell-dependent, might predict stronger associations with HLA class II than class I alleles, as noted in autoimmune thyroid disease with HLA-DR3 and other class II alleles<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935064">41</a></sup>, and also in SLE<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935023">15</a>, <a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935013">42</a></sup>. Although multiple immunoregulatory abnormalities have been mapped to the conserved 8.1 haplotype<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935036">14</a></sup> that contains both the DR3 and HLA-B*08 alleles, the causative locus (or loci) have not yet been clearly defined for any disease and almost certainly differ for different autoimmune phenotypes. In earlier reports, the HLA associations in EOMG have been stronger with the region including HLA class III and HLA-B*08 than with DR3<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935019">6</a>,<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935005">12</a>, <a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935075">13</a></sup>. With our much higher combined patient numbers and marker densities, as well as the newly available imputation methods and reference databases, B*08 now clearly emerges as the major risk allele in the MHC.</p><p id="P26">These novel findings demand a renewed focus on potential roles of the HLA-B*08 molecule itself in EOMG pathogenesis. We have previously hypothesized<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935077">7</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935054">12</a>, <a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935047">43</a></sup> that HLA-B8-restricted cytotoxic T-cells could (<strong>a</strong>) be primed by AChR subunits expressed by the hyperplastic thymic epithelial cells in EOMG, and then (<strong>b</strong>) attack rare thymic myoid cells that express intact AChR, the only cells outside muscle to do so<sup><a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935004">43</a></sup>. The resulting damage would lead to (<strong>c</strong>) the nearby germinal center responses, and thus to diversification of the ensuing autoantibodies so that they characteristically recognize the intact AChR in its native conformation. The current findings suggest that a search for HLA-B*08-restricted T-cells specific for likely autoimmunizing AChR epitopes<sup><a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_317238774">44</a></sup> would be a rational approach to extending this line of inquiry.</p><p id="P27">These data point to the continuing value of applying GWAS analysis to even modest-sized datasets of uncommon but well-defined complex autoimmune phenotypes. For many antibody-mediated autoimmune disorders, <em>PTPN22</em> is the strongest non-MHC genetic risk factor<sup><a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_317238773">45</a></sup>, and appears to be mediated by an amino acid change R620W encoded by rs2476601, although the precise mechanisms underlying this association remain controversial<sup><a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935016">46</a>, <a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935020">47</a></sup>. Indeed, we confirmed that signals from all other marginally associated markers in PTPN22 were completely eliminated after conditioning on rs2476601 (data not shown). The similar effect sizes of the associations of EOMG with both <em>TNIP1</em> and <em>PTPN22</em> are striking. In addition, the identification of a putative functional amino acid change in the TNIP1 protein is a novel finding and illustrates the power of combining imputation with GWAS data. It will be important to investigate the genotype-phenotype correlations with this TNIP1 variant as well as other genes in the ubiquitin and NF-κB pathways that are likely to contribute to the pathogenesis of autoimmune disorders. Indeed, several additional genes involved in binding to, or enzymatic modification of, ubiquitin have recently shown associations with human autoimmunity in GWAS studies<sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935045">9</a></sup>.</p><p id="P28">Previous studies have identified promoter polymorphisms at the nicotinic cholinergic receptor alpha 1 (CHRNA1) locus were specifically associated with very early age of onset (before age 20) of EOMG, and also interacted with AIRE<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291935041">10</a></sup>. Although our EOMG GWAS showed no association signal at the CHRNA1 (p &gt; 0.05 for all SNPS +/− 200 kb) we did note nominal significance for very early age onset EOMG (162 cases with age of onset &lt; age 20; p=0.038) for rs2646165, the only SNP on our genotyping arrays that captures the relevant promoter haplotype.</p><p id="P29" class="p p-last">Notably, the three loci mapped here account for a large fraction of the genetic risk for EOMG. For B*08, PTPN22 and TNIP1, the population attributable risks (PAR) were 52.3%, 12.6%, and 11.0%, respectively – or 62.9% overall. Nevertheless, the limited statistical power must have precluded detection of numerous weaker associations. For high-frequency alleles (e.g. 0.4), our study had &gt;80% power to detect loci with modest ORs (1.2) in additive models, whereas, for lower-frequency susceptibility alleles (e.g. 0.1), that could only be achieved where ORs were substantially higher (&gt;1.7). Since most predisposing loci detected in GWAS in autoimmune diseases have modest effect sizes, further larger studies are clearly essential for complete analyses of EOMG genetics.</p></div><div id="S15" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S15title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>Supp Figure S1</h4><div class="sup-box half_rhythm" id="d35e1029"><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Figure_S1.TIF" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(176K, TIF)</sup></div></div><div class="sec suppmat" id="SD2"><h4>Supp Table S1</h4><div class="sup-box half_rhythm" id="d35e1033"><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(195K, pdf)</sup></div></div><div class="sec suppmat" id="SD3"><h4>Supp Table S2</h4><div class="sup-box half_rhythm" id="d35e1037"><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S2.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(476K, pdf)</sup></div></div><div class="sec suppmat" id="SD4"><h4>Supp Table S3</h4><div class="sup-box half_rhythm" id="d35e1041"><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S3.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(234K, pdf)</sup></div></div><div class="sec suppmat" id="SD5"><h4>Supp Table S4</h4><div class="sup-box half_rhythm" id="d35e1045"><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supp_Table_S4.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(454K, pdf)</sup></div></div><div class="sec suppmat" id="SD6"><h4>Supplementary Data</h4><div class="sup-box half_rhythm" id="d35e1049"><a href="/pmc/articles/PMC3535539/bin/NIHMS392966-supplement-Supplementary_Data.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(62K, doc)</sup></div></div></div><div id="S16" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S16title">Acknowledgments</h2><div class="sec"><p id="__p1">This work was supported by a grant from the National Institutes of Health to PKG (NIH/NIAID RO1-AI-68759) and grants from the Palle Ferb Foundation and the Swedish Research Council (LH and QPH), and the UK Medical Research Council (NW). We are grateful to the many Norwegian neurologists who have contributed to the collection of Norwegian MG samples, which was funded through grants from Norwegian Health Authorities South East. Norwegian controls were provided by the Norwegian Bone Marrow Registry. The Dutch contribution to this work was partly supported by a grant from the Prinses Beatrix Fonds; we also thank E. Bakker in the Department of Human Genetics, Leiden University Medical Center, the Myasthenia Gravis Association in the UK, and the many patients and their physicians in the UK who generously participated in this study.</p></div></div><div id="GL" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="GLtitle">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td id="G1">AChR</td><td>acetylcholine receptor</td></tr><tr><td id="G2">EOMG</td><td>early-onset myasthenia gravis</td></tr><tr><td id="G3">GWAS</td><td>genome-wide association study</td></tr><tr><td id="G4">HLA</td><td>human leukocyte antigen</td></tr><tr><td id="G5">LPS</td><td>lipo-polysaccharide</td></tr><tr><td id="G6">MHC</td><td>major histocompatibility complex</td></tr><tr><td id="G7">PCA</td><td>principal components analysis</td></tr><tr><td id="G8">PTPN22</td><td>Protein tyrosine phosphatase, non-receptor type 22</td></tr><tr><td id="G9">SLE</td><td>systemic lupus erythematosus</td></tr><tr><td id="G10">TLR</td><td>toll-like receptor</td></tr><tr><td id="G11">TNF</td><td>tumor necrosis factor</td></tr><tr><td id="G12">TNIP1</td><td>TNFAIP3-interacting protein 1</td></tr><tr><td id="G13">SNP</td><td>single nucleotide polymorphism</td></tr></tbody></table></div></div></div><div id="idm139868359518496" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139868359518496title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. <span><span class="ref-journal">Lancet Neurology. </span>2009 May;<span class="ref-vol">8</span>(5):475–90.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2730933/">PMC free article</a>]</span> [<a href="/pubmed/19375665" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Neurology&amp;title=Autoimmune+myasthenia+gravis:+emerging+clinical+and+biological+heterogeneity&amp;author=MN+Meriggioli&amp;author=DB+Sanders&amp;volume=8&amp;issue=5&amp;publication_year=2009&amp;pages=475-90&amp;pmid=19375665&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. <span><span class="ref-journal">Lancet. </span>2001 Jun 30;<span class="ref-vol">357</span>(9274):2122–8.</span> [<a href="/pubmed/11445126" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Myasthenia+gravis&amp;author=A+Vincent&amp;author=J+Palace&amp;author=D+Hilton-Jones&amp;volume=357&amp;issue=9274&amp;publication_year=2001&amp;pages=2122-8&amp;pmid=11445126&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Mantegazza R, Bonanno S, Camera G, Antozzi C. Current and emerging therapies for the treatment of myasthenia gravis. <span><span class="ref-journal">Neuropsychiatric Disease and Treatment. </span>2011;<span class="ref-vol">7</span>:151–60.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3083988/">PMC free article</a>]</span> [<a href="/pubmed/21552317" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychiatric+Disease+and+Treatment&amp;title=Current+and+emerging+therapies+for+the+treatment+of+myasthenia+gravis&amp;author=R+Mantegazza&amp;author=S+Bonanno&amp;author=G+Camera&amp;author=C+Antozzi&amp;volume=7&amp;publication_year=2011&amp;pages=151-60&amp;pmid=21552317&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. <span><span class="ref-journal">BMC Neurol. </span>2010;<span class="ref-vol">10</span>:46.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2905354/">PMC free article</a>]</span> [<a href="/pubmed/20565885" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Neurol&amp;title=A+systematic+review+of+population+based+epidemiological+studies+in+Myasthenia+Gravis&amp;author=AS+Carr&amp;author=CR+Cardwell&amp;author=PO+McCarron&amp;author=J+McConville&amp;volume=10&amp;publication_year=2010&amp;pages=46&amp;pmid=20565885&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Giraud M, Beaurain G, Yamamoto AM, et al.  Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. <span><span class="ref-journal">Neurology. </span>2001 Nov 13;<span class="ref-vol">57</span>(9):1555–60.</span> [<a href="/pubmed/11706089" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Linkage+of+HLA+to+myasthenia+gravis+and+genetic+heterogeneity+depending+on+anti-titin+antibodies&amp;author=M+Giraud&amp;author=G+Beaurain&amp;author=AM+Yamamoto&amp;volume=57&amp;issue=9&amp;publication_year=2001&amp;pages=1555-60&amp;pmid=11706089&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Marx A, Willcox N, Leite MI, et al.  Thymoma and paraneoplastic myasthenia gravis. <span><span class="ref-journal">Autoimmunity. </span>2010 Aug;<span class="ref-vol">43</span>(5–6):413–27.</span> [<a href="/pubmed/20380583" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmunity&amp;title=Thymoma+and+paraneoplastic+myasthenia+gravis&amp;author=A+Marx&amp;author=N+Willcox&amp;author=MI+Leite&amp;volume=43&amp;issue=5–6&amp;publication_year=2010&amp;pages=413-27&amp;pmid=20380583&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Beeson D, Bond AP, Corlett L, et al.  Thymus, thymoma, and specific T cells in myasthenia gravis. <span><span class="ref-journal">Annals of the New York Academy of Sciences. </span>1998 May 13;<span class="ref-vol">841</span>:371–87.</span> [<a href="/pubmed/9668262" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=Thymus,+thymoma,+and+specific+T+cells+in+myasthenia+gravis&amp;author=D+Beeson&amp;author=AP+Bond&amp;author=L+Corlett&amp;volume=841&amp;publication_year=1998&amp;pages=371-87&amp;pmid=9668262&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Vandiedonck C, Capdevielle C, Giraud M, et al.  Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. <span><span class="ref-journal">Ann Neurol. </span>2006 Feb;<span class="ref-vol">59</span>(2):404–7.</span> [<a href="/pubmed/16437561" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;title=Association+of+the+PTPN22*R620W+polymorphism+with+autoimmune+myasthenia+gravis&amp;author=C+Vandiedonck&amp;author=C+Capdevielle&amp;author=M+Giraud&amp;volume=59&amp;issue=2&amp;publication_year=2006&amp;pages=404-7&amp;pmid=16437561&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. <span><span class="ref-journal">The New England Journal of Medicine. </span>2011 Oct 27;<span class="ref-vol">365</span>(17):1612–23.</span> [<a href="/pubmed/22029983" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+New+England+Journal+of+Medicine&amp;title=Genomics+and+the+multifactorial+nature+of+human+autoimmune+disease&amp;author=JH+Cho&amp;author=PK+Gregersen&amp;volume=365&amp;issue=17&amp;publication_year=2011&amp;pages=1612-23&amp;pmid=22029983&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Giraud M, Taubert R, Vandiedonck C, et al.  An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. <span><span class="ref-journal">Nature. </span>2007 Aug 23;<span class="ref-vol">448</span>(7156):934–7.</span> [<a href="/pubmed/17687331" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=An+IRF8-binding+promoter+variant+and+AIRE+control+CHRNA1+promiscuous+expression+in+thymus&amp;author=M+Giraud&amp;author=R+Taubert&amp;author=C+Vandiedonck&amp;volume=448&amp;issue=7156&amp;publication_year=2007&amp;pages=934-7&amp;pmid=17687331&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Pirskanen R. Genetic associations between myasthenia gravis and the HL-A system. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1976 Jan;<span class="ref-vol">39</span>(1):23–33.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC492209/">PMC free article</a>]</span> [<a href="/pubmed/1255208" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&amp;title=Genetic+associations+between+myasthenia+gravis+and+the+HL-A+system&amp;author=R+Pirskanen&amp;volume=39&amp;issue=1&amp;publication_year=1976&amp;pages=23-33&amp;pmid=1255208&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Janer M, Cowland A, Picard J, et al.  A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C. <span><span class="ref-journal">Hum Immunol. </span>1999 Sep;<span class="ref-vol">60</span>(9):909–17.</span> [<a href="/pubmed/10527401" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Immunol&amp;title=A+susceptibility+region+for+myasthenia+gravis+extending+into+the+HLA-class+I+sector+telomeric+to+HLA-C&amp;author=M+Janer&amp;author=A+Cowland&amp;author=J+Picard&amp;volume=60&amp;issue=9&amp;publication_year=1999&amp;pages=909-17&amp;pmid=10527401&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Vandiedonck C, Beaurain G, Giraud M, et al.  Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004 Oct 26;<span class="ref-vol">101</span>(43):15464–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC524438/">PMC free article</a>]</span> [<a href="/pubmed/15489265" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Pleiotropic+effects+of+the+8.1+HLA+haplotype+in+patients+with+autoimmune+myasthenia+gravis+and+thymus+hyperplasia&amp;author=C+Vandiedonck&amp;author=G+Beaurain&amp;author=M+Giraud&amp;volume=101&amp;issue=43&amp;publication_year=2004&amp;pages=15464-9&amp;pmid=15489265&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Price P, Witt C, Allcock R, et al.  The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. <span><span class="ref-journal">Immunol Rev. </span>1999;<span class="ref-vol">167</span>:257–74.</span> [<a href="/pubmed/10319267" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Rev&amp;title=The+genetic+basis+for+the+association+of+the+8.1+ancestral+haplotype+(A1,+B8,+DR3)+with+multiple+immunopathological+diseases&amp;author=P+Price&amp;author=C+Witt&amp;author=R+Allcock&amp;volume=167&amp;publication_year=1999&amp;pages=257-74&amp;pmid=10319267&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Graham RR, Ortmann WA, Langefeld CD, et al.  Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. <span><span class="ref-journal">Am J Hum Genet. </span>2002 Sep;<span class="ref-vol">71</span>(3):543–53.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC379191/">PMC free article</a>]</span> [<a href="/pubmed/12145745" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Visualizing+human+leukocyte+antigen+class+II+risk+haplotypes+in+human+systemic+lupus+erythematosus&amp;author=RR+Graham&amp;author=WA+Ortmann&amp;author=CD+Langefeld&amp;volume=71&amp;issue=3&amp;publication_year=2002&amp;pages=543-53&amp;pmid=12145745&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Rioux JD, Goyette P, Vyse TJ, et al.  Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009 Nov 3;<span class="ref-vol">106</span>(44):18680–5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2773992/">PMC free article</a>]</span> [<a href="/pubmed/19846760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Mapping+of+multiple+susceptibility+variants+within+the+MHC+region+for+7+immune-mediated+diseases&amp;author=JD+Rioux&amp;author=P+Goyette&amp;author=TJ+Vyse&amp;volume=106&amp;issue=44&amp;publication_year=2009&amp;pages=18680-5&amp;pmid=19846760&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Pereyra F, Jia X, McLaren PJ, et al.  The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. <span><span class="ref-journal">Science. </span>2010 Dec 10;<span class="ref-vol">330</span>(6010):1551–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3235490/">PMC free article</a>]</span> [<a href="/pubmed/21051598" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+major+genetic+determinants+of+HIV-1+control+affect+HLA+class+I+peptide+presentation&amp;author=F+Pereyra&amp;author=X+Jia&amp;author=PJ+McLaren&amp;volume=330&amp;issue=6010&amp;publication_year=2010&amp;pages=1551-7&amp;pmid=21051598&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Purcell S, Neale B, Todd-Brown K, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007 Sep;<span class="ref-vol">81</span>(3):559–75.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;volume=81&amp;issue=3&amp;publication_year=2007&amp;pages=559-75&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. <span><span class="ref-journal">Genetics. </span>2000 Jun;<span class="ref-vol">155</span>(2):945–59.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1461096/">PMC free article</a>]</span> [<a href="/pubmed/10835412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Inference+of+population+structure+using+multilocus+genotype+data&amp;author=JK+Pritchard&amp;author=M+Stephens&amp;author=P+Donnelly&amp;volume=155&amp;issue=2&amp;publication_year=2000&amp;pages=945-59&amp;pmid=10835412&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. <span><span class="ref-journal">Genetics. </span>2003 Aug;<span class="ref-vol">164</span>(4):1567–87.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1462648/">PMC free article</a>]</span> [<a href="/pubmed/12930761" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Inference+of+population+structure+using+multilocus+genotype+data:+linked+loci+and+correlated+allele+frequencies&amp;author=D+Falush&amp;author=M+Stephens&amp;author=JK+Pritchard&amp;volume=164&amp;issue=4&amp;publication_year=2003&amp;pages=1567-87&amp;pmid=12930761&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Kosoy R, Nassir R, Tian C, et al.  Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. <span><span class="ref-journal">Human Mutation. </span>2009 Jan;<span class="ref-vol">30</span>(1):69–78.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3073397/">PMC free article</a>]</span> [<a href="/pubmed/18683858" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Mutation&amp;title=Ancestry+informative+marker+sets+for+determining+continental+origin+and+admixture+proportions+in+common+populations+in+America&amp;author=R+Kosoy&amp;author=R+Nassir&amp;author=C+Tian&amp;volume=30&amp;issue=1&amp;publication_year=2009&amp;pages=69-78&amp;pmid=18683858&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Frazer KA, Ballinger DG, Cox DR, et al.  A second generation human haplotype map of over 3.1 million SNPs. <span><span class="ref-journal">Nature. </span>2007 Oct 18;<span class="ref-vol">449</span>(7164):851–61.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689609/">PMC free article</a>]</span> [<a href="/pubmed/17943122" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+second+generation+human+haplotype+map+of+over+3.1+million+SNPs&amp;author=KA+Frazer&amp;author=DG+Ballinger&amp;author=DR+Cox&amp;volume=449&amp;issue=7164&amp;publication_year=2007&amp;pages=851-61&amp;pmid=17943122&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Browning BL, Browning SR. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. <span><span class="ref-journal">Am J Hum Genet. </span>2009 Feb;<span class="ref-vol">84</span>(2):210–23.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2668004/">PMC free article</a>]</span> [<a href="/pubmed/19200528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=A+unified+approach+to+genotype+imputation+and+haplotype-phase+inference+for+large+data+sets+of+trios+and+unrelated+individuals&amp;author=BL+Browning&amp;author=SR+Browning&amp;volume=84&amp;issue=2&amp;publication_year=2009&amp;pages=210-23&amp;pmid=19200528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Marchini J, Howie B. Genotype imputation for genome-wide association studies. <span><span class="ref-journal">Nat Rev Genet. </span>2010 Jun 2;<span class="ref-vol">11</span>(7):499–511.</span> [<a href="/pubmed/20517342" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=Genotype+imputation+for+genome-wide+association+studies&amp;author=J+Marchini&amp;author=B+Howie&amp;volume=11&amp;issue=7&amp;publication_year=2010&amp;pages=499-511&amp;pmid=20517342&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Barrett JC, Clayton DG, Concannon P, et al.  Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. <span><span class="ref-journal">Nat Genet. </span>2009 May 10;</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2889014/">PMC free article</a>]</span> [<a href="/pubmed/19430480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+and+meta-analysis+find+that+over+40+loci+affect+risk+of+type+1+diabetes&amp;author=JC+Barrett&amp;author=DG+Clayton&amp;author=P+Concannon&amp;publication_year=2009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Flesher DL, Sun X, Behrens TW, Graham RR, Criswell LA. Recent advances in the genetics of systemic lupus erythematosus. <span><span class="ref-journal">Expert Review of Clinical Immunology. </span>2010 May;<span class="ref-vol">6</span>(3):461–79.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2897739/">PMC free article</a>]</span> [<a href="/pubmed/20441431" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Review+of+Clinical+Immunology&amp;title=Recent+advances+in+the+genetics+of+systemic+lupus+erythematosus&amp;author=DL+Flesher&amp;author=X+Sun&amp;author=TW+Behrens&amp;author=RR+Graham&amp;author=LA+Criswell&amp;volume=6&amp;issue=3&amp;publication_year=2010&amp;pages=461-79&amp;pmid=20441431&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Stahl EA, Raychaudhuri S, Remmers EF, et al.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. <span><span class="ref-journal">Nat Genet. </span>2010 Jun;<span class="ref-vol">42</span>(6):508–14.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4243840/">PMC free article</a>]</span> [<a href="/pubmed/20453842" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+meta-analysis+identifies+seven+new+rheumatoid+arthritis+risk+loci&amp;author=EA+Stahl&amp;author=S+Raychaudhuri&amp;author=EF+Remmers&amp;volume=42&amp;issue=6&amp;publication_year=2010&amp;pages=508-14&amp;pmid=20453842&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Mao ZF, Yang LX, Mo XA, et al.  Frequency of autoimmune diseases in myasthenia gravis: a systematic review. <span><span class="ref-journal">The International Journal of Neuroscience. </span>Mar;<span class="ref-vol">121</span>(3):121–9.</span> [<a href="/pubmed/21142828" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+International+Journal+of+Neuroscience&amp;title=Frequency+of+autoimmune+diseases+in+myasthenia+gravis:+a+systematic+review&amp;author=ZF+Mao&amp;author=LX+Yang&amp;author=XA+Mo&amp;volume=121&amp;issue=3&amp;pages=121-9&amp;pmid=21142828&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Verstrepen L, Carpentier I, Verhelst K, Beyaert R. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. <span><span class="ref-journal">Biochemical Pharmacology. </span>2009 Jul 15;<span class="ref-vol">78</span>(2):105–14.</span> [<a href="/pubmed/19464428" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+Pharmacology&amp;title=ABINs:+A20+binding+inhibitors+of+NF-kappa+B+and+apoptosis+signaling&amp;author=L+Verstrepen&amp;author=I+Carpentier&amp;author=K+Verhelst&amp;author=R+Beyaert&amp;volume=78&amp;issue=2&amp;publication_year=2009&amp;pages=105-14&amp;pmid=19464428&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Oshima S, Turer EE, Callahan JA, et al.  ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. <span><span class="ref-journal">Nature. </span>2009 Feb 12;<span class="ref-vol">457</span>(7231):906–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2642523/">PMC free article</a>]</span> [<a href="/pubmed/19060883" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=ABIN-1+is+a+ubiquitin+sensor+that+restricts+cell+death+and+sustains+embryonic+development&amp;author=S+Oshima&amp;author=EE+Turer&amp;author=JA+Callahan&amp;volume=457&amp;issue=7231&amp;publication_year=2009&amp;pages=906-9&amp;pmid=19060883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Nanda SK, Venigalla RK, Ordureau A, et al.  Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. <span><span class="ref-journal">J Exp Med. </span><span class="ref-vol">208</span>(6):1215–28.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3173241/">PMC free article</a>]</span> [<a href="/pubmed/21606507" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Polyubiquitin+binding+to+ABIN1+is+required+to+prevent+autoimmunity&amp;author=SK+Nanda&amp;author=RK+Venigalla&amp;author=A+Ordureau&amp;volume=208&amp;issue=6&amp;pages=1215-28&amp;pmid=21606507&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Zhou J, Wu R, High AA, et al.  A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011 Nov 1;<span class="ref-vol">108</span>(44):E998–1006.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3207663/">PMC free article</a>]</span> [<a href="/pubmed/22011580" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=A20-binding+inhibitor+of+NF-kappaB+(ABIN1)+controls+Toll-like+receptor-mediated+CCAAT/enhancer-binding+protein+beta+activation+and+protects+from+inflammatory+disease&amp;author=J+Zhou&amp;author=R+Wu&amp;author=AA+High&amp;volume=108&amp;issue=44&amp;publication_year=2011&amp;pages=E998-1006&amp;pmid=22011580&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Adzhubei IA, Schmidt S, Peshkin L, et al.  A method and server for predicting damaging missense mutations. <span><span class="ref-journal">Nature Methods. </span>Apr;<span class="ref-vol">7</span>(4):248–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2855889/">PMC free article</a>]</span> [<a href="/pubmed/20354512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Methods&amp;title=A+method+and+server+for+predicting+damaging+missense+mutations&amp;author=IA+Adzhubei&amp;author=S+Schmidt&amp;author=L+Peshkin&amp;volume=7&amp;issue=4&amp;pages=248-9&amp;pmid=20354512&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Yue P, Melamud E, Moult J. SNPs3D: candidate gene and SNP selection for association studies. <span><span class="ref-journal">BMC Bioinformatics. </span>2006;<span class="ref-vol">7</span>:166.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1435944/">PMC free article</a>]</span> [<a href="/pubmed/16551372" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Bioinformatics&amp;title=SNPs3D:+candidate+gene+and+SNP+selection+for+association+studies&amp;author=P+Yue&amp;author=E+Melamud&amp;author=J+Moult&amp;volume=7&amp;publication_year=2006&amp;pages=166&amp;pmid=16551372&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Menard L, Saadoun D, Isnardi I, et al.  The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. <span><span class="ref-journal">J Clin Invest. </span>2011;<span class="ref-vol">121</span>:3635–3644.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3163953/">PMC free article</a>]</span> [<a href="/pubmed/21804190" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=The+PTPN22+allele+encoding+an+R620W+variant+interferes+with+the+removal+of+developing+autoreactive+B+cells+in+humans&amp;author=L+Menard&amp;author=D+Saadoun&amp;author=I+Isnardi&amp;volume=121&amp;publication_year=2011&amp;pages=3635-3644&amp;pmid=21804190&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Gateva V, Sandling JK, Hom G, et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. <span><span class="ref-journal">Nat Genet. </span>2009 Nov;<span class="ref-vol">41</span>(11):1228–33.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2925843/">PMC free article</a>]</span> [<a href="/pubmed/19838195" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+large-scale+replication+study+identifies+TNIP1,+PRDM1,+JAZF1,+UHRF1BP1+and+IL10+as+risk+loci+for+systemic+lupus+erythematosus&amp;author=V+Gateva&amp;author=JK+Sandling&amp;author=G+Hom&amp;volume=41&amp;issue=11&amp;publication_year=2009&amp;pages=1228-33&amp;pmid=19838195&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Allanore Y, Saad M, Dieude P, et al.  Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. <span><span class="ref-journal">PLoS Genet. </span>2011 Jul;<span class="ref-vol">7</span>(7):e1002091.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3131285/">PMC free article</a>]</span> [<a href="/pubmed/21750679" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Genome-wide+scan+identifies+TNIP1,+PSORS1C1,+and+RHOB+as+novel+risk+loci+for+systemic+sclerosis&amp;author=Y+Allanore&amp;author=M+Saad&amp;author=P+Dieude&amp;volume=7&amp;issue=7&amp;publication_year=2011&amp;pages=e1002091&amp;pmid=21750679&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Bowes J, Orozco G, Flynn E, et al.  Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. <span><span class="ref-journal">Ann Rheum Dis. </span>2011 Sep;<span class="ref-vol">70</span>(9):1641–4.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3147229/">PMC free article</a>]</span> [<a href="/pubmed/21623003" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Confirmation+of+TNIP1+and+IL23A+as+susceptibility+loci+for+psoriatic+arthritis&amp;author=J+Bowes&amp;author=G+Orozco&amp;author=E+Flynn&amp;volume=70&amp;issue=9&amp;publication_year=2011&amp;pages=1641-4&amp;pmid=21623003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Hughes T, Adler A, Merrill JT, et al.  Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. <span><span class="ref-journal">Ann Rheum Dis. </span>2011;<span class="ref-vol">71</span>:694–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3324666/">PMC free article</a>]</span> [<a href="/pubmed/22110124" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Analysis+of+autosomal+genes+reveals+gene-sex+interactions+and+higher+total+genetic+risk+in+men+with+systemic+lupus+erythematosus&amp;author=T+Hughes&amp;author=A+Adler&amp;author=JT+Merrill&amp;volume=71&amp;publication_year=2011&amp;pages=694-9&amp;pmid=22110124&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Nancy P, Berrih-Aknin S. Differential estrogen receptor expression in autoimmune myasthenia gravis. <span><span class="ref-journal">Endocrinology. </span>2005 May;<span class="ref-vol">146</span>(5):2345–53.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1839841/">PMC free article</a>]</span> [<a href="/pubmed/15661863" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Differential+estrogen+receptor+expression+in+autoimmune+myasthenia+gravis&amp;author=P+Nancy&amp;author=S+Berrih-Aknin&amp;volume=146&amp;issue=5&amp;publication_year=2005&amp;pages=2345-53&amp;pmid=15661863&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Zeitlin AA, Heward JM, Newby PR, et al.  Analysis of HLA class II genes in Hashimoto’s thyroiditis reveals differences compared to Graves’ disease. <span><span class="ref-journal">Genes Immun. </span>2008 Jun;<span class="ref-vol">9</span>(4):358–63.</span> [<a href="/pubmed/18449200" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Immun&amp;title=Analysis+of+HLA+class+II+genes+in+Hashimoto’s+thyroiditis+reveals+differences+compared+to+Graves’+disease&amp;author=AA+Zeitlin&amp;author=JM+Heward&amp;author=PR+Newby&amp;volume=9&amp;issue=4&amp;publication_year=2008&amp;pages=358-63&amp;pmid=18449200&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Graham RR, Ortmann W, Rodine P, et al.  Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:823–30.</span> [<a href="/pubmed/17406641" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Hum+Genet&amp;title=Specific+combinations+of+HLA-DR2+and+DR3+class+II+haplotypes+contribute+graded+risk+for+disease+susceptibility+and+autoantibodies+in+human+SLE&amp;author=RR+Graham&amp;author=W+Ortmann&amp;author=P+Rodine&amp;volume=15&amp;publication_year=2007&amp;pages=823-30&amp;pmid=17406641&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Willcox N, Leite MI, Kadota Y, et al.  Autoimmunizing mechanisms in thymoma and thymus. <span><span class="ref-journal">Annals of the New York Academy of Sciences. </span>2008;<span class="ref-vol">1132</span>:163–73.</span> [<a href="/pubmed/18567866" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=Autoimmunizing+mechanisms+in+thymoma+and+thymus&amp;author=N+Willcox&amp;author=MI+Leite&amp;author=Y+Kadota&amp;volume=1132&amp;publication_year=2008&amp;pages=163-73&amp;pmid=18567866&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Maclennan CA, Vincent A, Marx A, et al.  Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis. <span><span class="ref-journal">J Neuroimmunol. </span>2008 Sep 15;<span class="ref-vol">201–202</span>:28–32.</span> [<a href="/pubmed/18657869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;title=Preferential+expression+of+AChR+epsilon-subunit+in+thymomas+from+patients+with+myasthenia+gravis&amp;author=CA+Maclennan&amp;author=A+Vincent&amp;author=A+Marx&amp;volume=201–202&amp;publication_year=2008&amp;pages=28-32&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">Gregersen PK, Olsson LM. Recent advances in the genetics of autoimmune disease. <span><span class="ref-journal">Annual Review of Immunology. </span>2009;<span class="ref-vol">27</span>:363–91.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2992886/">PMC free article</a>]</span> [<a href="/pubmed/19302045" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annual+Review+of+Immunology&amp;title=Recent+advances+in+the+genetics+of+autoimmune+disease&amp;author=PK+Gregersen&amp;author=LM+Olsson&amp;volume=27&amp;publication_year=2009&amp;pages=363-91&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Zhang J, Zahir N, Jiang Q, et al.  The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. <span><span class="ref-journal">Nat Genet. </span>2011 Sep;<span class="ref-vol">43</span>(9):902–7.</span> [<a href="/pubmed/21841778" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=The+autoimmune+disease-associated+PTPN22+variant+promotes+calpain-mediated+Lyp/Pep+degradation+associated+with+lymphocyte+and+dendritic+cell+hyperresponsiveness&amp;author=J+Zhang&amp;author=N+Zahir&amp;author=Q+Jiang&amp;volume=43&amp;issue=9&amp;publication_year=2011&amp;pages=902-7&amp;pmid=21841778&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Vang T, Liu WH, Delacroix L, et al.  LYP inhibits T-cell activation when dissociated from CSK. <span><span class="ref-journal">Nat Chem Biol. </span>2012;<span class="ref-vol">8</span>(5):437–46.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3329573/">PMC free article</a>]</span> [<a href="/pubmed/22426112" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Chem+Biol&amp;title=LYP+inhibits+T-cell+activation+when+dissociated+from+CSK&amp;author=T+Vang&amp;author=WH+Liu&amp;author=L+Delacroix&amp;volume=8&amp;issue=5&amp;publication_year=2012&amp;pages=437-46&amp;pmid=22426112&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3535539&amp;issue-id=217751&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139868355736816title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Materials and Methods</a></li><li><a href="#S13title">Results</a></li><li><a href="#S14title">Discussion</a></li><li><a href="#S15title">Supplementary Material</a></li><li><a href="#S16title">Acknowledgments</a></li><li><a href="#GLtitle">Abbreviations</a></li><li><a href="#idm139868359518496title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3535539/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3535539/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3535539/pdf/nihms392966.pdf">PDF (1.3M)</a></li> | <li><a href="#" data-citationid="PMC3535539" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3535539%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3535539%2F&amp;text=Risk%20for%20Myasthenia%20Gravis%20maps%20to%20151Pro%E2%86%92%20Ala%20change%20in%20TNIP1%20and%20to%20HLA-B*08" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3535539%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23055271" data-aiid="3535539" data-aid="3535539" data-iid="217751" data-domainid="319" data-domain="nihpa" data-accid="PMC3535539" data-md5="fdf8aad7557fb6b9decb643e345141bb"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T09:41:40-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal103&amp;ncbi_phid=CE8A992DDD543B1100000000097C0628&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3535539%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3535539/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>